바이오인

Pricing & Market Access Outlook 2014 Edition

I. Recalibrating the pharma mindset
- Organizational stress test: Is your company fit for payer purpose?
- Integrating patient journeys and funding flows
- Balancing geographic priorities in clinical trial design

II. Partnering opportunities
- Beyond the Pill: Two truths and a lie
- Rethinking RWE: Partnering with payers

III. Funding challenges
- Exs: Should pharma care?
- Private insurance as an access lever in emerging markets
- List price premiums in US and EU: What are the implications?
- Payment by use: A new value paradigm for oncology

IV. Shifting sands
- Opportunity hidden in plain sight: A return to primary care
- Mind the gap: Expectation versus reality in the EU biosimilar market

...................(계속)

☞ 자세한 내용은 첨부파일을  이용하시기 바랍니다.